Stock FinancialsFinanzen börsennotierter US-Firmen

WATERS CORP /DE/ WAT

Laboratory Analytical Instruments · NYSE

Umsatz
$2.96B
-0.5% Jahresübergangsrate
Nettoerlös
$642.23M
-9.3% Jahresübergangsrate
Gesamtvermögen
$4.55B
-1.6% Jahresübergangsrate
EPS
10.84
-7.6% Jahresübergangsrate
Bruttogewinnspanne 37.9% Betriebsergebnis 27.7% Nettomarge 21.7% Einsendungen
Advertisement
Einkommensrechnung
Zeitraum 2026 Q22026 Q12025 FY2025 Q32025 Q22025 Q12024 FY2024 Q3
Revenues $1.43B $662.00M $2.96B $2.09B $1.35B $636.84M $2.97B $2.14B
Cost of Revenue — — — — — — — —
Gross Profit — — — — — — — —
R&D Expense $95.00M $47.00M $174.94M $136.11M $90.78M $44.59M $176.19M $130.56M
SG&A Expense $373.00M $174.00M $736.01M $516.88M $347.78M $174.54M $658.03M $555.66M
Operating Income (Loss) $340.00M $152.00M $817.68M $534.09M $322.96M $133.85M $873.39M $553.45M
Interest Expense $28.00M $14.00M $98.86M $70.68M $49.25M $25.52M $48.80M $68.16M
Net Income (Loss) $268.00M $121.00M $642.23M $406.44M $244.93M $102.20M $707.75M —
EPS (Diluted) 4.50 2.03 10.84 6.83 4.12 1.72 11.73 7.19
Bilanz
Zeitraum 2026 Q22026 Q12025 FY2025 Q32025 Q22025 Q12024 FY2024 Q3
Total Assets $5.08B $5.08B $4.55B $4.55B $4.55B $4.55B $4.63B $4.63B
Current Assets $2.15B $2.15B $1.67B $1.67B $1.67B $1.67B $1.75B $1.75B
Cash & Equivalents $588.00M $588.00M $325.36M $325.36M $325.36M $325.36M $395.08M $395.08M
Accounts Receivable $829.00M $829.00M $733.37M $733.37M $733.37M $733.37M $702.17M $702.17M
Inventory $572.00M $572.00M $477.26M $477.26M $477.26M $477.26M $516.24M $516.24M
PP&E (Net) $642.00M $642.00M $639.07M $651.20M $651.20M $651.20M $582.22M $639.07M
Goodwill $1.34B $1.34B $1.30B $1.30B $1.30B $1.30B $864.00M $1.31B
Total Liabilities $2.52B $2.52B $2.73B $2.73B $2.73B $2.73B $3.48B $3.48B
Current Liabilities $1.24B $1.24B $789.76M $789.76M $789.76M $789.76M $789.58M $789.58M
Accounts Payable $104.00M $104.00M $99.93M $99.93M $99.93M $99.93M $84.70M $84.70M
Long-Term Debt — — $1.41B — — — $1.63B —
Stockholders Equity $1.83B $1.83B $504.49M $1.15B $1.15B $1.15B $367.55M $504.49M
Kassenfluss
Zeitraum 2026 Q22026 Q12025 FY2025 Q32025 Q22025 Q12024 FY2024 Q3
Operating Cash Flow $301.00M $260.00M $602.81M $521.98M $317.40M $262.87M $611.66M $372.69M
Investing Cash Flow $-85.00M $-26.00M $-1.44B $-91.91M $-65.86M $-29.74M $-107.97M $-1.40B
Financing Cash Flow $-174.00M $-173.00M $754.95M $-503.10M $-326.21M $-292.18M $-509.63M $885.44M
Stock Repurchases $14.00M $14.00M $70.28M $13.47M $13.33M $13.09M $626.06M $70.43M

Ähnliche Firmen

Mehr erfahren

Daten stammen aus der öffentlichen Datenbank des US-amerikanischen SEC EDGAR. Diese Seite bietet keine Anlageberatung.